RecruitingNCT07369102
Esketamine with or without preparation and integration therapy for resistant depression
About this title
Read the official source — NCT07369102Medication studyAges 21–65United States
Understand this study
Who could participate?
Listed age limits: 21 years to 65 years.
- Listed locations
- San Juan and 1 more locationSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: February 1, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 20
- Sponsor
- University of Puerto Rico
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 21 Years to 65 Years
- Official registry ID
- NCT07369102
- Official title
Show the full official title
Esketamine With or Without Psychedelic Preparation and Integration for Treatment-Resistant Depression: A Randomized Controlled Trial
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
San Juan, Puerto Rico · United States
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Puerto Rico, a university.
Does this study involve medication?
Yes. The study involves medication, including Esketamine hydrochloride (intranasal).
Who can participate?
Listed age limits: 21 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
